Free Trial

Organigram Q3 2023 Earnings Report

Organigram logo
C$1.82 -0.01 (-0.55%)
As of 02/21/2025 04:00 PM Eastern

Organigram EPS Results

Actual EPS
-C$0.20
Consensus EPS
-C$0.08
Beat/Miss
Missed by -C$0.12
One Year Ago EPS
N/A

Organigram Revenue Results

Actual Revenue
$32.79 million
Expected Revenue
$42.89 million
Beat/Miss
Missed by -$10.10 million
YoY Revenue Growth
N/A

Organigram Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Organigram Earnings Headlines

Alliance Global Partners Estimates Organigram Q3 Earnings
Q3 EPS Estimates for Organigram Reduced by Atb Cap Markets
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.
See More Organigram Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram and other key companies, straight to your email.

About Organigram

Organigram (TSE:OGI) Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

View Organigram Profile

More Earnings Resources from MarketBeat